ReviewFrontiers in immunology2026

Efficacy and mechanisms of immune checkpoint inhibitors in late-stage EGFR-mutated non-small cell lung cancer following targeted therapy resistance.

Jiling Niu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.